When drawing up a list of which Trump nominees are likely to spark important confirmation fights on Capitol Hill, it's worth ...
The U.S. government could soon cover the cost of obesity drugs for millions of Americans through Medicare and Medicaid, ...
The Biden administration wants to expand coverage of anti-obesity medications to millions on Medicare, Medicaid.
The Biden administration is reinterpreting federal law to allow Medicare and Medicaid patients access to anti-obesity ...
The state discovered a glitch in its Medicaid eligibility system. The problem, alleged in court testimony, led to new mothers ...
Weight loss drugs like Wegovy, Zepbound and Ozempic would be covered by Medicare and Medicaid under a Biden administration ...
As officials put the change in draft rules for 2026, the incoming president's Medicare agency pick might support it.
Millions of Americans with obesity would be eligible to have popular weight-loss drugs like Wegovy or Ozempic co ...
The Biden administration said it would allow the program to pay for GLP-1 anti-obesity drugs, but the Trump administration ...
The outgoing Biden administration will propose that pricey GLP-1 obesity medications such as semaglutide (Wegovy), and ...
The proposal would expand coverage of anti-obesity drugs to 7.5 million people covered by Medicare and Medicaid, the Biden ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback